Participant Perceptions in a Long-term Clinical Trial of Autosomal Dominant Polycystic Kidney Disease

RATIONALE & OBJECTIVE: The development of new therapies for autosomal dominant polycystic kidney disease requires clinical trials to be conducted efficiently. In this study, the factors affecting the recruitment and retention of participants enrolled in a 3-year randomized controlled trial in au...

Descripción completa

Detalles Bibliográficos
Autores principales: Amin, Sneha, Sangadi, Irene, Allman-Farinelli, Margaret, Badve, Sunil V., Boudville, Neil, Coolican, Helen, Coulshed, Susan, Foster, Sheryl, Fernando, Mangalee, Haloob, Imad, Harris, David C.H., Hawley, Carmel M., Holt, Jane, Howell, Martin, Kumar, Karthik, Johnson, David W., Lee, Vincent W., Mai, Jun, Rangan, Anna, Roger, Simon D., Sud, Kamal, Torres, Vicente, Vilayur, Eswari, Rangan, Gopala K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432794/
https://www.ncbi.nlm.nih.gov/pubmed/37602144
http://dx.doi.org/10.1016/j.xkme.2023.100691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432794/
https://www.ncbi.nlm.nih.gov/pubmed/37602144
http://dx.doi.org/10.1016/j.xkme.2023.100691

Ejemplares similares